4//SEC Filing
During Matthew 4
Accession 0001209191-19-023196
CIK 0001636651other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:42 PM ET
Size
5.4 KB
Accession
0001209191-19-023196
Insider Transaction Report
Form 4
During Matthew
DirectorPresident and CSO10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2019-04-01+75,000→ 75,000 totalExercise: $1.76Exp: 2029-03-31→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of the shares will become exercisable immediately and the remaining shares shall vest monthly thereafter over subsequent three years subject to the Reporting Person's continued service through such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001704631
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:42 PM ET
- Size
- 5.4 KB